| pubmed-article:15306106 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0699885 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C1514888 | lld:lifeskim |
| pubmed-article:15306106 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:15306106 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15306106 | pubmed:dateCreated | 2004-8-12 | lld:pubmed |
| pubmed-article:15306106 | pubmed:abstractText | Neoadjuvant chemotherapy has been used to improve outcome after cystectomy or for selection for bladder preservation in patients with bladder cancer. We have shown encouraging results using docetaxel and cisplatin in patients with advanced urothelial cancer. We are reporting the results of a phase II study using this combination as neoadjuvant treatment in patients with muscle invasive bladder cancer. | lld:pubmed |
| pubmed-article:15306106 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15306106 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15306106 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15306106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15306106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15306106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15306106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15306106 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15306106 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15306106 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:Pantazopoulos... | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:DimopoulosM... | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:DeliveliotisC... | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:KarayiannisAA | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:ZervasII | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:BamiasAA | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:GikaDD | lld:pubmed |
| pubmed-article:15306106 | pubmed:author | pubmed-author:VarkarakisII | lld:pubmed |
| pubmed-article:15306106 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15306106 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:15306106 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15306106 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15306106 | pubmed:pagination | 344-50; discussion 350-1 | lld:pubmed |
| pubmed-article:15306106 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:meshHeading | pubmed-meshheading:15306106... | lld:pubmed |
| pubmed-article:15306106 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15306106 | pubmed:articleTitle | Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term results. | lld:pubmed |
| pubmed-article:15306106 | pubmed:affiliation | Department of Clinical Therapeutics, University of Athens, School of Medicine, Greece. abamias@med.uoa.gr | lld:pubmed |
| pubmed-article:15306106 | pubmed:publicationType | Journal Article | lld:pubmed |
